Optimization of Pharmaceutical R&D Programs and Portfolios
This book includes chapters written by authors with very broad backgrounds including financial, clinical, statistical, decision sciences, commercial, and regulatory. Many authors have long held executive positions and have been involved with decision making at a product or at a portfolio level. As...
Đã lưu trong:
| Tác giả chính: | |
|---|---|
| Định dạng: | Sách |
| Ngôn ngữ: | English |
| Được phát hành: |
Springer
2015
|
| Những chủ đề: | |
| Truy cập trực tuyến: | https://scholar.dlu.edu.vn/thuvienso/handle/DLU123456789/56145 |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
| Thư viện lưu trữ: | Thư viện Trường Đại học Đà Lạt |
|---|
| Tóm tắt: | This book includes chapters written by authors with very broad backgrounds
including financial, clinical, statistical, decision sciences, commercial, and regulatory. Many authors have long held executive positions and have been involved with
decision making at a product or at a portfolio level. As such, it is expected that this
book will attract a very broad audience, including decision makers in pharmaceutical
R & D, commercial, and financial departments. The intended audience also includes
portfolio planners and managers, statisticians, decision scientists, and clinicians.
Early chapters describe approaches to portfolio optimization from big Pharma
and Venture Capital standpoints. They have stronger focus on finances and processes. Later chapters present selected statistical and decision analysis methods... |
|---|